James Rodberg is CFO at Sight Sciences, Inc. (SGHT). They have made 6 open-market trades across 1 company since 2025, most recently 2026-10-02.
CIK 0001961970
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 6 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| SGHT | 216,829 | $1.8M |
Shares reported on the most recent Form 4, priced at the 2026-10-05 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| SGHT | SELL | 2026-10-02 | 2026-10-05 | $8.85 | $64K | -1.2% | — | — |
| SGHT | SELL | 2026-07-02 | 2026-07-06 | $5.36 | $37K | -4.1% | +1.8% | +63.7% |
| SGHT | SELL | 2026-04-06 | 2026-04-09 | $3.55 | $26K | +21.4% | +52.0% | +52.9% |
| SGHT | SELL | 2026-01-16 | 2026-01-21 | $6.62 | $17K | +0.8% | -15.5% | -33.5% |
| SGHT | SELL | 2026-01-05 | 2026-01-06 | $7.78 | $39K | -13.3% | -23.7% | -52.4% |
| SGHT | SELL | 2025-12-02 | 2025-12-03 | $8.25 | $21K | -3.5% | -13.1% | -38.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.